| Product NDC: | 0574-4005 | 
| Proprietary Name: | Epinastine Hydrochloride | 
| Non Proprietary Name: | Epinastine Hydrochloride | 
| Active Ingredient(s): | .5 mg/mL & nbsp; Epinastine Hydrochloride | 
| Administration Route(s): | OPHTHALMIC | 
| Dosage Form(s): | SOLUTION/ DROPS | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0574-4005 | 
| Labeler Name: | Paddock Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA090951 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20111101 | 
| Package NDC: | 0574-4005-05 | 
| Package Description: | 1 BOTTLE in 1 CARTON (0574-4005-05) > 5 mL in 1 BOTTLE | 
| NDC Code | 0574-4005-05 | 
| Proprietary Name | Epinastine Hydrochloride | 
| Package Description | 1 BOTTLE in 1 CARTON (0574-4005-05) > 5 mL in 1 BOTTLE | 
| Product NDC | 0574-4005 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Epinastine Hydrochloride | 
| Dosage Form Name | SOLUTION/ DROPS | 
| Route Name | OPHTHALMIC | 
| Start Marketing Date | 20111101 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Paddock Laboratories, Inc. | 
| Substance Name | EPINASTINE HYDROCHLORIDE | 
| Strength Number | .5 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Adrenergic Agonists [MoA],Adrenergic Receptor Agonist [EPC],Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |